Examining the Effects of Mitochondrial Oxidative Stress in DCM

Summary

Double blind, randomised, placebo-controlled trial of MitoQ (mitoquinol mesylate) in 106 patients with dilated cardiomyopathy, examining the effect of reducing mitochondrial oxidative stress on myocardial energetics and myocardial function using 31-phosphorus magnetic resonance spectroscopy and cardiovascular magnetic resonance.

Timeline

Start

2022-07-26

Primary completion

2024-06-19

Completion

2024-06-19

Drugs

Indications